Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside

Ramon Andrade de Mello; Giovanna Araújo Amaral

doi:10.3390/jcm9103376

Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside

J Clin Med. 2020 Oct 21;9(10):3376. doi: 10.3390/jcm9103376.

Authors

Ramon Andrade de Mello^{1

2

3}, Giovanna Araújo Amaral²

Affiliations

¹ Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine University of Algarve (DCBM UALG), 8005-139 Faro, Portugal.
² Division of Medical Oncology, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo 04037-004, Brazil.
³ Precision Oncology and Health Economics Group (ONCOPRECH), Post-Graduation Program in Medicine, Nine of July University (UNINOVE), São Paulo 01525-000, Brazil.

Abstract

Lung cancer (LC) is inarguably one of the biggest battles to be fought in the field of oncology, and non-small cell lung cancer accounts for over 85% of all lung cancer cases [...].

Publication types

Editorial